Drug Type Small molecule drug |
Synonyms- |
Target |
Action activators, inhibitors |
Mechanism AMP activated protein kinase activators(AMP activated protein kinase activators), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endocrinology and Metabolic Disease | Discovery | - | 09 Nov 2023 | |
Metabolic dysfunction-associated steatotic liver disease | Discovery | - | 09 Nov 2023 |